Φορτώνει......
Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress Glioblastoma Tumor Growth
PURPOSE: Glioblastoma (GBM) is classified as one of the most aggressive and lethal brain tumor. Great strides have been made in understanding the genomic and molecular underpinnings of GBM, which translated into development of new therapeutic approaches to combat such deadly disease. However, there...
Αποθηκεύτηκε σε:
Τόπος έκδοσης: | Cancer Res Treat |
---|---|
Κύριοι συγγραφείς: | , , , , , , , , , |
Μορφή: | Artigo |
Γλώσσα: | Inglês |
Έκδοση: |
Korean Cancer Association
2018
|
Θέματα: | |
Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6056981/ https://ncbi.nlm.nih.gov/pubmed/29129044 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2017.315 |
Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|